Stock Events

Stock Events

Kamada 

$7.65
54
-$0.11-1.42% 08:44 Today

Statistics

Day High
7.77
Day Low
7.76
52W High
9.35
52W Low
6.5
Volume
1,104
Avg. Volume
-
Mkt Cap
447.71M
P/E Ratio
20.34
Dividend Yield
3.22%
Dividend
0.25

Upcoming

Dividends

3.22%Dividend Yield
Apr 26
$0.25
Apr 25
$0.20
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

16NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
0.05
0.09
0.13
0.17
Expected EPS
0.1325
Actual EPS
N/A

Financials

11.19%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
180.46MRevenue
20.2MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow KMDA. It's not an investment recommendation.
NVIDIA
12
NVDA
Amazon
11
AMZN
Apple
10
AAPL
Micron Technology
9
MU

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Carlisle Companies
CSL
Mkt Cap14.7B
CSL Behring competes in the plasma-derived and recombinant therapeutic products space, similar to Kamada's focus areas.
Grifols SA
GRFS
Mkt Cap5.29B
Grifols operates in the plasma-derived biopharmaceuticals sector, directly competing with Kamada in the production of plasma-derived proteins.
Takeda Pharmaceutical
TAK
Mkt Cap56.3B
Takeda Pharmaceutical Company has a significant presence in the plasma-derived therapies market, making it a competitor in areas overlapping with Kamada's product offerings.
Baxter International
BAX
Mkt Cap13.82B
Baxter International produces biotherapeutic products, including plasma-based proteins that compete with Kamada's portfolio.
Adma Biologics
ADMA
Mkt Cap2.12B
ADMA Biologics specializes in the manufacture of plasma-derived products for immune deficiencies, competing in Kamada's market segment.
Pfizer
PFE
Mkt Cap152.69B
Pfizer has a broad range of biopharmaceutical products that can compete with Kamada's offerings, especially in the immunoglobulin and specialty plasma areas.
Biogen
BIIB
Mkt Cap31B
Biogen's focus on advanced therapies for treating neurological diseases and its investment in biologics can position it as a competitor in some of Kamada's therapeutic areas.
Abbott Laboratories
ABT
Mkt Cap192.51B
Abbott Laboratories, through its broad range of healthcare products, including diagnostics and medical devices, indirectly competes with Kamada in the broader healthcare market.
AMGEN
AMGN
Mkt Cap224.63B
Amgen's focus on biologic therapeutics and novel treatment options can make it a competitor in the biopharmaceutical space, potentially overlapping with Kamada's market.

About

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
Show more...
CEO
Amir London
Employees
462
Country
Israel
ISIN
IL0010941198

Listings

XNAS
US
KMDA
BOATS
BOATS
KMDA.BOATS
TA
IL
KMDA.TA

0 Comments

Share your thoughts

FAQ

What is Kamada stock price today?▼
The current price of KMDA is $7.65 USD — it has decreased by -1.42% in the past 24 hours. Watch Kamada stock price performance more closely on the chart.
What is Kamada stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Kamada stocks are traded under the ticker KMDA.
Is Kamada stock price growing?▼
KMDA stock has risen by +9.45% compared to the previous week, the month change is a +10.07% rise, over the last year Kamada has showed a +8.23% increase.
What is Kamada market cap?▼
Today Kamada has the market capitalization of 447.71M
When is the next Kamada earnings date?▼
Kamada is going to release the next earnings report on November 16, 2026.
What were Kamada earnings last quarter?▼
KMDA earnings for the last quarter are 0.17 USD per share, whereas the estimation was 0.11 USD resulting in a +53.28% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Kamada revenue for the last year?▼
Kamada revenue for the last year amounts to 180.46M USD.
What is Kamada net income for the last year?▼
KMDA net income for the last year is 20.2M USD.
Does Kamada pay dividends?▼
Yes, KMDA dividends are paid annual. The last dividend per share was 0.25 USD. As of today, Dividend Yield (FWD)% is 3.22%.
How many employees does Kamada have?▼
As of August 18, 2026, the company has 462 employees.
In which sector is Kamada located?▼
Kamada operates in the Health & Wellness sector.
When did Kamada complete a stock split?▼
Kamada has not had any recent stock splits.
Where is Kamada headquartered?▼
Kamada is headquartered in Rehovot, Israel.